The Pfizer developed Heat Wash-Out (HWO) system is a software controlled electromechanical system designed to measure vaginal wall blood flow. A small vaginal probe is attached to a control unit. Output data are collected on a PC. By measuring the clearance of heat from the heated probe, a direct measure of absolute blood flow can be obtained. The study will assess the technique's ability to differentiate between pre- and post-menopausal women; with and without Female Sexual Arousal Disorder (FSAD).
Medical Device Development
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Enrollment
64
No drug administered. Device tested twice with each subject.
Pfizer Investigational Site
Dulwich, South Australia, Australia
Pfizer Investigational Site
Nedlands, Western Australia, Australia
To assess the safety and toleration of the heat washout device.
Time frame: 2 weeks
To investigate differences in vaginal blood flow following visual sexual stimulation in pre-menopausal women with and without FSAD.
Time frame: 2 weeks
To investigate changes in subjective acute sexual arousal following visual sexual stimulation in women with and without FSAD.
Time frame: 2 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.